Tuesday, 25 August 2026

The Brief Journal

Editor's Brief

US consumer confidence hits its lowest point since January, oil slides sharply on eased Iran supply fears, and markets hold their breath ahead of Nvidia earnings and Fed Chair Warsh's Jackson Hole speech.

Daily Newsletter

The Brief Journal

Free briefing every morning.

Trade

Trump's 50% tariffs threaten Canadian GDP and jobs at scale

Fresh 50% US tariffs on Canadian goods are now in place, and economists estimate the levies could shave half a percentage point off Canada's GDP while eliminating tens of thousands of jobs. Business owners have warned the tariffs could cut off their US sales entirely. The dispute has sharpened, with Trump and Ontario Premier Doug Ford trading insults publicly and Trump floating the idea of renaming Lake Ontario to "Lake America."

Why it matters

Analysis: Tariffs at this scale represent a structural shift in Canada-US trade, not a negotiating gesture. Corporate exposure assessments, supply chain restructuring mandates, and cross-border contract reviews will accelerate across every sector with US revenue dependence.

Trade

Rising US tariffs put electronics prices at risk for Canadian consumers

While autos and steel have dominated trade-war headlines, analysts warn that escalating US tariffs will also push up prices for electronics, including AI hardware components, video games, and cellphones. The tariffs affect the physical supply chain underpinning consumer tech, not just finished goods. Canada has limited domestic alternatives for most of these categories.

Why it matters

Analysis: A tariff-driven electronics price shock would compress consumer spending and squeeze retailers and tech distributors with Canadian exposure, adding a new dimension to the inflation risk already weighing on the Bank of Canada's rate path.

Trade

Trump says US lacks aluminum as Canada trade row intensifies

President Trump publicly lamented a shortage of US domestic aluminum supply, comments that came as the Canada-US trade dispute reached new intensity. Canada remains one of the largest aluminum exporters to the United States. Trump's remarks reflect the structural contradiction in US trade policy: tariffs designed to protect domestic industry are being applied in sectors where domestic capacity cannot immediately substitute for imports.

Why it matters

Analysis: The aluminum shortage acknowledgement exposes the limits of tariff strategy and raises the prospect of carve-outs or targeted negotiations, creating near-term uncertainty for Canadian producers and their US counterparts locked into long-term supply contracts.

Capital Markets

Saudi mortgage refinancer's sukuk draws $18.7bn in orders on $2.75bn deal

Saudi Real Estate Refinance Company attracted $18.7 billion in orders for a $2.75 billion global sukuk, a near seven-times oversubscription. The deal was managed by Bahrain-based Al Salam Bank among others. Demand of this scale for a government-backed Saudi issuer signals sustained appetite for GCC fixed-income instruments among global investors.

Why it matters

Analysis: Oversubscription of this magnitude confirms that government-linked sukuk remains a high-conviction trade for international fixed-income allocators, reinforcing the GCC's capacity to raise large volumes of debt capital at competitive spreads even in a volatile rate environment.

Pharma

FDA grants Zymeworks' zanidatamab second approval in under two years

The US Food and Drug Administration approved Ziihera (zanidatamab-hrii), developed by Vancouver-based Zymeworks, in combination with tislelizumab and chemotherapy for first-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma. The approval covers all HER2+ patients regardless of PD-L1 status. It is the second FDA approval for zanidatamab in less than two years, further validating Zymeworks' proprietary Azymetric bispecific antibody platform.

Why it matters

Analysis: Back-to-back FDA approvals from the same platform strengthen Zymeworks' commercial pipeline and licensing optionality, and are likely to attract renewed partnership and out-licensing discussions with larger pharma players looking for validated oncology assets.

M&A

Greenland rare earth project valued at up to US$2.05bn with 118.6% pre-tax IRR

Greenland Mines' Sarfartoq neodymium-praseodymium rare earth project has been valued at up to US$2.05 billion in a maiden S-K 1300 economic study, with a pre-tax internal rate of return of 118.6%. Production from the ST1 deposit alone would represent approximately 34% of all NdPr oxide refined outside China at 2025 consumption levels. The project sits within a broader carbonatite district with further upside potential beyond the initial study scope.

Why it matters

Analysis: A project capable of supplying 34% of ex-China NdPr oxide carries direct strategic relevance for Western supply chain diversification in electric vehicles and defence applications, making it an immediate target for government-backed offtake discussions and project finance structures.